Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

9.10
Delayed Data
As of 4:00pm ET
 -0.23 / -2.47%
Today’s Change
7.12
Today|||52-Week Range
11.85
-9.45%
Year-to-Date
'Mad Money' Lightning Round: I Am Committed to Opko Health
Aug 30 / TheStreet.com - Paid Partner Content
Weekly CEO Buys
Aug 29 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close9.33
Today’s open9.26
Day’s range9.07 - 9.26
Volume2,793,264
Average volume (3 months)3,251,714
Market cap$5.1B
Dividend yield--
Data as of 4:00pm ET, 08/31/2016

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-30.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratio30.9
Price/Sales9.97
Price/Book2.57

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+0.37+0.30%
TAROTaro Pharmaceutical ...0.000.00%
ENDPEndo International P...-0.19-0.91%
TSROTESARO Inc-1.40-1.63%
Data as of 4:02pm ET, 08/31/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts

Search for Jobs